Search Results - "KAFANDO, E"

Extended red blood cell antigens and phenotypes in Burkina Faso: potential issues to design local population-sourced red blood cell reagent panels by Sawadogo, S, Nebie, K, Ouedraogo, S K A, Traore, C, Koulidiati, J, Nikiema-Minoungou, M, Koala, N G, Kafando, E, Deneys, V

“…To date, 43 blood group systems with 349 red blood cell (RBC) antigens have been recognized. The study of their distribution is useful for blood services to…”
Get more information

Prospective cohort of COVID-19 patients requiring hospital admission in Douala, Cameroon by Tchamgoué, S., Ntep Eboko, M., Makamté, A., Ngagnia, A., Talla-Mba, F., Nitcheu Wendi, O., Kafando, E., Tengang, B., Sandjon, J.P., Tattevin, P.

“…•Data on COVID-19 patients hospitalized in low-income countries are scarce.•In clinics with no access to mechanical ventilation, the 28-day mortality was…”
Get full text

Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: Lessons from pilot studies by Tshilolo, L, Kafando, E, Sawadogo, M, Cotton, F, Vertongen, F, Ferster, A, Gulbis, B

“…Summary Objectives Despite the widespread use of neonatal screening programmes for sickle cell disease in Western regions, few studies have focused on the…”
Get full text

Factors associated with the satisfaction of prescribers of blood products in Burkina Faso by Sawadogo, S, Kafando, E, Nébié, K, Ouédraogo, A-S, Ouattara, S, Dahourou, H, Fretz, C, Deneys, V

“…The National Blood Transfusion Centre, unique operator of blood transfusion in Burkina Faso is engaged into the quality process according to ISO 9001…”
Get more information

The main BCR-ABL mRNA transcript types and hematological features of newly diagnosed chronic myeloid leukemia in Burkina Faso by D. Kima, Y. Esther Hien, M. Nikiéma, F. Sanou, C. Zoungrana, E. Kafando, Y. Traoré

“…Objective: Chronic myeloid leukemia (CML) is characterized by the Philadelphia chromosome with an abnormally shortened chromosome 22, which is the result of a…”
Get full text

Role of quality control for improvement of blood components in the Regional Blood Centre of Ouagadougou in Burkina Faso, 2014 by Nebie, K, Sawadogo, S, Kafando, E, Bationo, E M, Dahourou, H, Ouattara, S, Kienou, K, Nana, S, Kaba, L, Fretz, C, Murphy, E L

“…In Burkina Faso, blood components must comply with national standards. Then, all Transfusion services must implement a quality control process to ensure…”
Get more information

Neonatal haemoglobinopathy screening in Burkina Faso by Kafando, E, Nacoulma, E, Ouattara, Y, Ayéroué, J, Cotton, F, Sawadogo, M, Gulbis, B

“…To report our experience of neonatal screening for sickle cell disease in Ouagadougou (Burkina Faso) and to discuss the feasibility of neonatal screening in…”
Get more information

Prevalence of Chronic Complications of Sickle Cell Disease at the Bobo-Dioulasso Teaching Hospital, Burkina Faso by Traoré, C, Kyelem, C G, Semdé, A, Koulidiati, J, Sanou, A F, Bokoum, S, Kafando, E

Get full text

Pernicious anemia: diagnosis and course in Burkina Faso by Koulidiati, J, Sawadogo, S, Sagna, Y, Somda, K S, Tieno, H, Kafando, E, Drabo, Y J

“…Pernicious anemia (also known as Biermer disease or anemia, Addison or Addisonian anemia, and Addison-Biermer anemia) is an autoimmune atrophic gastritis…”
Get more information

Hemoglobin sickle cell disease: experience of the Yalgado Ouedraogo University Hospital of Ouagadougou, Burkina Faso by Ayéroué, J, Kafando, E, Kam, L, Gué, E, Vertongen, F, Ferster, A, Cotton, F, Gulbis, B

“…To evaluate the clinical features of children with hemoglobin sickle cell disease (HbSC) and compare them to children with sickle cell anemia (HbSS). This was…”
Get full text

Iron deficiency anaemia: clinical presentation, biological diagnosis and management by Espanel, C, Kafando, E, Hérault, B, Petit, A, Herault, O, Binet, C

“…The iron deficiency is the first cause of anaemia. In healthy young adult, anemia is well tolerated because of its progressive installation. The most common…”
Get full text

PO024 Association of V617F JAK2 mutation and myelodysplastic 5q-syndrome without anemia by Espanel, C, Herault, O, Kafando, E, Bacq, Y, Barin, C, Petit, A, Binet, C, Domenech, J

Get full text

Le syndrome drépanocytaire de type hémoglobine SC : expérience du CHU Yalgado Ouédraogo de Ouagadougou (Burkina Faso) by Ayéroué, J., Kafando, E., Kam, L., Gué, E., Vertongen, F., Ferster, A., Cotton, F., Gulbis, B.

“…Comparer le tableau clinique des enfants drépanocytaires de type hétérozygote composite SC (HbSC) par rapport aux enfants drépanocytaires homozygotes pour…”
Get full text

Pathologies rhumatologiques et hémoglobinopathies à Ouagadougou (Burkina Faso) by Ouédraogo, D. -D., Nacoulma, E. W. C., Kafando, E., Ouédraogo, A., Tiéno, H., Koulidiaty, J., Drabo, J. Y.

“…Résumé Cette étude porte sur la prévalence des complications rhumatologiques de la drépanocytose et sur les associations entre les hémoglobinopathies et les…”
Get full text

Anémies ferriprives : signes d’appel, diagnostic et prise en charge by Espanel, C., Kafando, E., Hérault, B., Petit, A., Herault, O., Binet, C.

“…La carence martiale est la première cause d’anémie. Chez le sujet jeune sans facteur de comorbidité elle est bien tolérée car souvent d’installation…”
Get full text

Seroprevalence and factors associated with IgG anti‐DENV positivity in blood donors in Burkina Faso during the 2016 dengue outbreak and implications for blood supply by Sawadogo, Salam, Baguiya, Adama, Yougbare, Fiffou, Bicaba, Brice Wilfried, Nebie, Koumpingnin, Millogo, Tieba, Kamba, Ibrahim, Kaba, Losseni, Sangare, Lassana, Kafando, Eléonore, Deneys, Véronique

“…Summary Objectives Our study aimed to update the seroprevalence and factors associated with anti‐dengue virus (DENV) antibody positivity among blood donors and…”
Get full text

Faible niveau de connaissances des donneurs de sang au Burkina Faso ; une entrave potentielle à la sécurité transfusionnelle by Nébié, K.Y., Olinger, C.M., Kafando, E., Dahourou, H., Diallo, S., Kientega, Y., Domo, Y., Kienou, K., Ouattara, S., Sawadogo, I., Ky, L., Muller, C.P.

“…Parmi les mesures préconisées pour réduire le risque infectieux transfusionnel, figure la sélection clinique prédon, au cours de laquelle on recherche de tares…”
Get full text

Disponibilité et coût des traitements de base de la drépanocytose dans 13 pays africains by Keza, G.K., Diallo, D., Diagne, I., De Montalembert, M., Corbasson, A., Bernaudin, F., Ranque, B., Diop, S., Coulibaly, B., Hermine, O., Lainé, A., Galactéros, F., Vodouhé, C., Kafando, E., Vovor, A., Belinga, S., Tshilolo, L., Jan, S., Hue, R., Arlet, J.B.

Get full text

Mortalité infanto-juvénile liée à la drépanocytose en Afrique subsaharienne : étude multinationale en Afrique de l’ouest et du centre by Ranque, B., Kitenge, R., Coulibaly, C., Traore, H., Adjoumani, L., Ba, M., Doucoure, D., Diallo, D., Kafando, E., Tolo, A., Tshilolo, L., Diagne, I.

“…En France comme dans les pays du nord, la quasi totalité des enfants drépanocytaires atteint désormais l’age adulte, mais la mortalité infanto-juvénile liée à…”
Get full text

Prévalence des complications chroniques de la drépanocytose au CHU de Bobo-Dioulasso, Burkina Faso by TRAORÉ, C, KYELEM, C G, SEMDÉ, A, KOULIDIATI, J, Sanou, A F, Bokoum, S, KAFANDO, E

“…Il s’est agi d’une étude transversale descriptive unicentrique à collecte prospective des données de la fréquence des complications chroniques de la…”
Get full text